Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MARK4 inhibitor 1 5mg | 2271081-58-2 | 5 MG
SDP

Catalog No. 5000307522
Encompass_Preferred

MARK4 inhibitor 1 is a selective small-molecule inhibitor of microtubule affinity-regulating kinase 4 (MARK4) used for in vitro and preclinical research into MARK4-mediated signaling, apoptosis, and cancer cell biology. Supplied as a powder with reported high purity and standard storage recommendations.

  • Selective MARK4 inhibitor with reported IC50 1.54 μM.
  • Molecular formula C20H18N6O3; molecular weight 390.40.
  • Reported purity 98.3% (manufacturer-reported).
  • Soluble in DMSO (approx. 5 mg/mL with ultrasonication; pH adjustment may be required).
  • Supplied as a powder with manufacturer-recommended storage conditions.

Catalog No. 50-003-07522 Supplier Medchemexpress LLC Supplier No. HY1143175MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MARK4 inhibitor 1 is a selective small-molecule inhibitor of microtubule affinity-regulating kinase 4 (MARK4) used for in vitro and preclinical research into MARK4-mediated signaling, apoptosis, and cancer cell biology. Supplied as a powder with reported high purity and standard storage recommendations.

  • Selective MARK4 inhibitor with reported IC50 1.54 μM.
  • Molecular formula C20H18N6O3; molecular weight 390.40.
  • Reported purity 98.3% (manufacturer-reported).
  • Soluble in DMSO (approx. 5 mg/mL with ultrasonication; pH adjustment may be required).
  • Supplied as a powder with manufacturer-recommended storage conditions.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.